{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:38:07Z","timestamp":1780983487720,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"am","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.canrad.2018.07.138","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T18:58:31Z","timestamp":1554231511000},"page":"104-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Radioth\u00e9rapie en conditions st\u00e9r\u00e9otaxiques du carcinome h\u00e9patocellulaire\u00a0: r\u00e9sultats d\u2019une \u00e9tude r\u00e9trospective multicentrique"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1221-4076","authenticated-orcid":false,"given":"N.","family":"Scher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Janoray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3349-2529","authenticated-orcid":false,"given":"F.-G.","family":"Riet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-G.","family":"Le Bayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Debbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Louisot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Garaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chajon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Barillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9.","family":"Salam\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"de Crevoisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chapet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Calais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2018.07.138_bib0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.canrad.2018.07.138_bib0230","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.canrad.2018.07.138_bib0235","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jviscsurg.2010.02.003","article-title":"Hepatocellular carcinoma\u00a0\u2014\u00a0what's new?","volume":"147","author":"Vullierme","year":"2010","journal-title":"J Visc Surg"},{"key":"10.1016\/j.canrad.2018.07.138_bib0240","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/SLA.0b013e3181bd582b","article-title":"Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation","volume":"250","author":"Cherqui","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2018.07.138_bib0245","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.canrad.2018.07.138_bib0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gcb.2007.11.001","article-title":"Utilisation du soraf\u00e9nib (Nexavar\u00ae) dans le traitement du carcinome h\u00e9patocellulaire\u00a0: recommandations Prodige Afef","volume":"32","author":"Boige","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0255","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2018.07.138_bib0260","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.canrad.2010.02.013","article-title":"Dose de tol\u00e9rance \u00e0 l\u2019irradiation des tissus sains\u00a0: le foie","volume":"14","author":"De Bari","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2018.07.138_bib0265","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ijrobp.2006.06.015","article-title":"Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies\u00a0\u2014\u00a0mature results of the French Phase II RTF-1\u00a0trial","volume":"66","author":"Mornex","year":"2006","journal-title":"Int J Radiat Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2018.07.138_bib0270","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/02841869509127197","article-title":"Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients","volume":"34","author":"Blomgren","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0275","series-title":"Radioth\u00e9rapie en conditions st\u00e9r\u00e9otaxiques des tumeurs h\u00e9patiques","author":"Anon","year":"2016"},{"key":"10.1016\/j.canrad.2018.07.138_bib0280","doi-asserted-by":"crossref","first-page":"047","DOI":"10.1055\/s-2006-939841","article-title":"Epidemiology of primary and secondary liver cancers","volume":"23","author":"Ananthakrishnan","year":"2006","journal-title":"Semin Interv Radiol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0285","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach\u00a0\u2014\u00a0The ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0290","series-title":"Quel niveau de qualit\u00e9 de traitement peut \u00eatre obtenu par un syst\u00e8me d\u2019irradiation robotis\u00e9 guid\u00e9 par l\u2019image en radioth\u00e9rapie (CyberKnife\u2122)","author":"Al Khawaja","year":"2011"},{"issue":"1","key":"10.1016\/j.canrad.2018.07.138_bib0295","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijrobp.2014.05.002","article-title":"Novel technique for hepatic fiducial marker placement for stereotactic body radiation therapy","volume":"90","author":"Jarraya","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0300","doi-asserted-by":"crossref","first-page":"e5591","DOI":"10.1097\/MD.0000000000005591","article-title":"Short-term and long-term efficacy of 7\u00a0targeted therapies for the treatment of advanced hepatocellular carcinoma: a network meta-analysis","volume":"95","author":"Niu","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.canrad.2018.07.138_bib0305","doi-asserted-by":"crossref","first-page":"vii41","DOI":"10.1093\/annonc\/mds225","article-title":"Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Verslype","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0310","doi-asserted-by":"crossref","first-page":"350","DOI":"10.6004\/jnccn.2009.0027","article-title":"NCCN clinical practice guidelines in oncology: hepatobiliary cancers","volume":"7","author":"Benson","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.canrad.2018.07.138_bib0315","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jjco\/hyi236","article-title":"Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma","volume":"36","author":"Choi","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0320","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jso.21593","article-title":"Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma","volume":"102","author":"Seo","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0325","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/cncr.27533","article-title":"Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization: a single-institution phase 2\u00a0trial","volume":"118","author":"Kang","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2018.07.138_bib0330","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijrobp.2011.11.058","article-title":"Stereotactic body radiation therapy in recurrent hepatocellular carcinoma","volume":"84","author":"Huang","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0335","doi-asserted-by":"crossref","first-page":"e77472","DOI":"10.1371\/journal.pone.0077472","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity","volume":"8","author":"Bibault","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canrad.2018.07.138_bib0340","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2015.04.006","article-title":"Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma","volume":"115","author":"Huertas","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0345","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/0284186X.2013.820342","article-title":"Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185\u00a0patients","volume":"53","author":"Sanuki","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0350","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00432-015-1929-y","article-title":"The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT)","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0355","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0360","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000000032","article-title":"Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolization","volume":"26","author":"Lo","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0365","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2018.07.138_bib0370","first-page":"10","article-title":"Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer","author":"Kwon","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2018.07.138_bib0375","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/153303461000900506","article-title":"Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results","volume":"9","author":"Louis","year":"2010","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.canrad.2018.07.138_bib0380","doi-asserted-by":"crossref","first-page":"e68193","DOI":"10.1371\/journal.pone.0068193","article-title":"Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization","volume":"8","author":"Zhong","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canrad.2018.07.138_bib0385","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.3748\/wjg.v19.i26.4106","article-title":"Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma","volume":"19","author":"Cucchetti","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0390","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ajg.2014.152","article-title":"Transarterial chemoembolization vs. radiofrequency ablation for the treatment of single hepatocellular carcinoma 2cm or smaller","volume":"109","author":"Kim","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0395","first-page":"12","article-title":"Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers","author":"Shimohigashi","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0400","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semradonc.2009.11.004","article-title":"Adaptive management of liver cancer radiotherapy","volume":"20","author":"Brock","year":"2010","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1748-717X-9-11","article-title":"Adequacy of inhale\/exhale breathhold CT based ITV margins and image-guided registration for free-breathing pancreas and liver SBRT","volume":"9","author":"Yang","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0410","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1748-717X-5-73","article-title":"Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: definition of clinical target volume for radiotherapy","volume":"5","author":"Wang","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0415","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.canrad.2017.07.028","article-title":"Radioth\u00e9rapie st\u00e9r\u00e9otaxique h\u00e9patique\u00a0: organes \u00e0 risque, marges d\u2019incertitudes, doses","volume":"21","author":"Lacornerie","year":"2017","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2018.07.138_bib0420","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/0284186X.2013.820342","article-title":"Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185\u00a0patients","volume":"53","author":"Sanuki","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0425","doi-asserted-by":"crossref","first-page":"e79854","DOI":"10.1371\/journal.pone.0079854","article-title":"Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma","volume":"8","author":"Yoon","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canrad.2018.07.138_bib0430","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2015.04.006","article-title":"Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma","volume":"115","author":"Huertas","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2018.07.138_bib0435","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canrad.2011.06.005","article-title":"Radioth\u00e9rapie st\u00e9r\u00e9otaxique h\u00e9patique par CyberKnife\u00ae\u00a0: l\u2019exp\u00e9rience lilloise","volume":"16","author":"Dewas","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2018.07.138_bib0220","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/cncr.27533","article-title":"Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization: a single-institution phase 2\u00a0trial","volume":"118","author":"Kang","year":"2012","journal-title":"Cancer"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321819300290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321819300290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:29:06Z","timestamp":1761136146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321819300290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1278321819300290"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2018.07.138","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radioth\u00e9rapie en conditions st\u00e9r\u00e9otaxiques du carcinome h\u00e9patocellulaire\u00a0: r\u00e9sultats d\u2019une \u00e9tude r\u00e9trospective multicentrique","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2018.07.138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}